Antipsychotic Drugs Linked to Increased Mortality Among Parkinson's Disease Patients
Penn and VA-led study analyzed medical records of 15,000 Parkinson’s patients
With Parkinson’s, there is a good chance that patients will experience some type of psychosis at some point during the course of their illness. During this time, most physicians prescribe antipsychotic drug to treat their symptoms. In a new study by researchers at the Perelman School of Medicine at the University of Pennsylvania, the University of Michigan Medical School and the Philadelphia and Ann Arbor Veterans Affairs (VA) Medical Centers, findings indicate that these antipsychotic drugs may be doing more harm than good to patients. Click here to read more on this study.
GOODMAN Oral Board Preparation Course Tumor
Nov. 1-3, 2017; Glendale, Ariz.
2017 From Cranial to Spine: An Overview of Neurosurgical Topics for the Advanced Practice Provider
Aug. 30-Sept. 2, 2017; Chicago
Mayo Clinic Neuroscience and Oncology Innovation Summit 2017
Sept. 7-9, 2017; Orlando, Fla.
63rd Annual Meeting of the Western Neurological Society
Sept. 8-11, 2017; Banff, Alberta, Canada
6th Homburger Neuroendoscopy Week
Sept. 11-15, 2017; Germany